In the practice of medicine, physicians are always reviewing new therapies and procedures, ensuring that patients always benefit from state-of-the-art thinking. For over 60 years, the Pap smear has been used in the practice of gynecology and is credited for essentially revolutionizing a physician’s ability to detect abnormalities of the cervix. One limit of the traditional Pap smear, however, is that it may not always detect very early changes in the cervix that could eventually lead to cancer. It is important to see these changes as soon as possible, because early detection followed by appropriate treatment is important to successful therapy for cervical disease.
PapSure is a relatively new test that combines the traditional Pap smear with an enhanced ability to view the cervix and vagina with a magnified lens plus Speculite, a disposable light for vaginal illumination, during a routine examination. The advantage of PapSure is that it significantly improves the ability to identify cervical abnormalities, and thus represents a new revolution in the detection of cervical disease.
Taken from PapSure Brochure
PapSure does not replace the Pap smear. Rather, the two complement each other and therefore can help prevent abnormalities from “falling through the cracks.” It is quick, easy and above all, painless.
PapSure is recognized by the Association of Professors of Gynecology and Obstetrics as a screening tool for cervical cancer. In studies, PapSure allowed detection of more than 4 times the number of total lesions as Pap smear alone.
Because PapSure is a newer product, it is not covered by insurance. Consequently, there is a fee of $55 if you decide to have this visual exam as part of your routine checkup. The fee will cover the cost of the Speculite light and the PapSure visual exam.